Shalby Limited has strengthened its position in subsidiary PK Healthcare Private Limited (PKHPL) by increasing its shareholding from 87.26% to 91.13% through a rights issue completed on February 28, 2026. The healthcare company invested ₹59,60,19,500 to acquire additional equity shares, reinforcing its strategic presence in the Delhi/NCR healthcare market.

Rights Issue Details

The rights issue involved the allotment of 5,96,01,950 equity shares of face value ₹10 each at a price of ₹10 per share. The issue was offered to all existing shareholders in the ratio of 1 new equity share for every 2 existing equity shares held as on the record date of January 24, 2026.

Shareholding Changes

Following the rights issue completion, Shalby's shareholding in PKHPL has increased significantly, demonstrating the company's commitment to expanding its subsidiary operations.

The subsidiary's paid-up share capital post-allotment stands at 19,62,15,850 equity shares of ₹10 each, amounting to ₹196,21,58,500.

PK Healthcare Background and Performance

PK Healthcare Private Limited was acquired by Shalby in January 2024 as part of the company's strategy to accelerate its presence in the Delhi/NCR region. The acquisition aimed to scale up international business operations and deliver quality healthcare services in northern India.

The subsidiary has demonstrated consistent financial growth over the past three years:

Fund Utilization

The funds raised through the rights issue will be deployed for multiple strategic purposes to strengthen PKHPL's operational capabilities. The company has outlined the following utilization areas:

• Repayment of existing debt obligations
• Working capital requirements
• General corporate purposes

This capital infusion is expected to support the subsidiary's continued growth trajectory and enhance its ability to provide comprehensive and advanced medical facilities to patients in the northern region. The transaction represents Shalby's ongoing commitment to expanding its healthcare network and strengthening its market position through strategic investments in subsidiary operations.

Shalby Limited has issued a postal ballot notice for the re-appointment of Mr. Shyamal Shivkumar Joshi as an Independent Director for a second consecutive term of 5 years. The Board of Directors had previously approved this decision at their meeting held on February 11, 2026, which commenced at 5:58 p.m. and concluded at 6:45 p.m.

Postal Ballot Notice and E-voting Details

The company has sent the postal ballot notice electronically to all members on February 17, 2026, whose names appeared in the Register of Members as on the cut-off date of Friday, February 13, 2026. The notice is also available on the company's website at www.shalby.org .

E-voting Schedule and Process

Shareholders can cast their votes through remote e-voting facility during the specified period. The company has engaged NSDL to provide secure electronic voting services to all members.

Director Re-appointment Details

The re-appointment was approved based on the recommendation of the Nomination and Remuneration Committee and requires shareholder approval through the postal ballot process. The company has ensured full compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Scrutinizer Appointment and Compliance

The company has appointed Mr. Chintan Patel (CP No. 20103), Proprietor of M/s. Chintan I Patel & Associates, Practicing Company Secretaries, as the Scrutinizer to conduct the postal ballot process in a fair and transparent manner. The scrutinizer will submit the report within two working days of the e-voting conclusion.

Mr. Joshi has been associated with Shalby Hospitals since 2010 and brings significant expertise in corporate strategy development, fundraising and capital management, mergers and acquisitions, taxation and regulatory compliance, and accounting and financial management. He is a commerce graduate from Gujarat University and a practicing Chartered Accountant with extensive experience across multiple domains.

Source: